Morning Briefing
Summaries of health policy coverage from major news organizations
Research Roundup: The Latest Science, Discoveries, And Breakthroughs
ABC News: Pregnancy Outcomes Could Be Significantly Impacted By Men's Health, Study Suggests
A new study suggests men's health may significantly influence their partners' pregnancy outcomes, as well as their children's future health. The new review, published in the journal The Lancet on Monday, analyzed multiple studies and concluded that a man's health prior to conception, including their mental health, nutrition, lifestyle choices like smoking, and environmental factors, may all have an impact on their partner's pregnancy. (Jinnah and Yu, 3/17)
MedPage Today: Prehospital Whole-Blood Transfusion No Better Than Standard For Severe Hemorrhage
Logistical advantages and safety aside, whole-blood transfusion offered no clinical improvement for the treatment of life-threatening hemorrhage in the prehospital setting, the randomized SWiFT trial found. (Lou, 3/17)
CIDRAP: Shingles Vaccine Tied To Half The Risk Of Cardiac Events In Older Adults With Heart Disease
Shingles vaccination may halve the one-year risk of serious cardiac events among older adults who have heart disease, adding to accumulating evidence that the vaccine may protect against health conditions in addition to shingles (herpes zoster), University of California researchers say. The study findings will be presented at the upcoming American College of Cardiology’s Annual Scientific Session in New Orleans. (Van Beusekom, 3/17)
MedPage Today: Hidradenitis Suppurativa Linked To Higher Risk Of Self-Harm, Including Suicide
Patients with hidradenitis suppurative (HS) had a significantly higher incidence of self-harm, including suicide, compared with the general population, a large registry-based study from Denmark showed. (Bankhead, 3/16)
Becker's Hospital Review: Telehealth Helps Breast Cancer Patients Adhere To Treatment: Study
Telehealth use is associated with higher adherence to endocrine therapy among women with breast cancer, according to a study in the Journal of Cancer Survivorship. Researchers from Athens-based University of Georgia analyzed claims data from the Merative MarketScan database, examining more than 1,100 commercially insured women under age 65 who were diagnosed with nonmetastatic breast cancer and started endocrine therapy in 2018 and followed for five years after. (Bruce, 3/16)
